Poultry production has been affected by multiple respiratory diseases triggering serious economic losses in Egypt. The current study aimed to investigate the situation and genetic evolution of respiratory diseases in Egypt during 2020. A total of 53 samples were collected from infected flocks suffering from respiratory signs and variable mortality rates from nine governorates in Egypt during 2020. The collected samples were examined for the detection of respiratory disease viruses (Avian influenza virus (AIV (H5N8, H9N2), Infectious bronchitis virus (IBV), and Newcastle disease virus (NDV)) by rRT-PCR. The single infection was confirmed in 90.6% (37.7% I.B, 30.2% AIV (H5N8), 9.4% I.B and 5.7% NDV) and co-infection of HPAIV (H5N8) + I.BV and LPAIV (H9N2) +IBV were detected in 3.8% of nine governorates. The HA gene of HPAIV (H5N8) was cluster to clad 2.3.4.4.1b in a new branch with characteristic specific mutations especially in T140A in antigenic site A and R72S in the receptor-binding site, compared to A/duck/Egypt/F446/2017 with low A.A identity percent with vaccinal strains of H5N1 and H5N2 reaching to 91.9-94% and 84.6%, respectively. The HA gene of AIV (H9N2) belonged to A/quail/Hong Kong/G1/97-like virus clustered with group B with a specific mutation (212I) that may affect the human transmission of the virus. The HVRs of S1 gene of IBV cluster to GI23 (Egy Var I) clad with multiple mutations in HVR1 and HVR2, compared to IBV/CU/4/2014 and low identity percent (68.3-78.8%) with vaccine strains (H120, M41, 4/91). In conclusion, respiratory disease continues to circulate and rapidly evolve in Egypt during 2020.
The present study was designed to throw the light on isolation of Escherichia coli (E. coli) strains accompanied by Infectious bronchitis virus (IBV). Classification and serotyping of bacterial isolates of E.coli were done followed by their antimicrobial susceptibility testing, also isolation and identification of IBV was done. For that purpose, a total of 200 organs, swap and samples were aseptically collected from broilers and layers flocks suffered from respiratory symptoms and general illness from both private and governmental farms during the period from 2015 till the end of 2017. Results revealed that the prevalence of E. coli was 67.5% and IBV was 61.5% in the collected samples. The serological identification showed that the most predominant serotype for E. coli was O 158 and there was a high level of resistance of isolated strains against doxycycline and tetracycline.
Poultry production has affected by multiple respiratory disease triggering serious economic losses in Egypt. In this study, the situation and genetic evolution of respiratory disease in Egypt during 2020 were studied. We collected 53 samples from infected flocks suffered from respiratory signs and variable mortality rate from nine governorates in Egypt during 2020. The collected samples were examined for detection of respiratory disease viruses (Avian influenza virus (AIV), Infectious bronchitis virus (IBV), and Newcastle disease virus (NDV)) by rRT-PCR. The single infection was confirmed in 90.6% (37.7% I. B, 30.2% AIV (H5N8), 9.4% I. B and 5.7% NDV) and co-infection of HPAIV (H5N8) + I.BV and LPAIV (H9N2) +IBV were detected in 3.8% in nine governorates. The HA gene of HPAIV (H5N8) were cluster to clad 2.3.4.4.1b in new branch with characteristic specific mutations especially in T140A in antigenic site A and R72S in the receptor binding site when comparing with A/duck/Egypt/F446/2017 with low A.A identity percent with vaccinal strains (H5N1 and H5N2) reach to 91.9-94% and 84.6% respectively. The HA gene of AIV (H9N2) were belong to A/quail/Hong Kong/G1/97-like virus clustered with group B with specific mutation (212I) that may be effect on human transmission of the virus. The HVRs of S1 gene of IBV cluster to GI23 (Egy Var I) clad with multiple mutation in HVR1, HVR2 when comparing with IBV/CU/4/2014 and low identity percent (68.3%-78.8%) with vaccine strains (H120, M41, 4/91). In conclusion, the respiratory disease continues circulate and rapidly evolved in Egypt during 2020.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.